{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:57:07Z","timestamp":1775869027140,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11457-1","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T14:27:16Z","timestamp":1752848836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using machine learning to discover DNA metabolism biomarkers that direct prostate cancer treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Ali Shakeri","family":"Abroudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melika","family":"Djamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"1","key":"11457_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12672-024-01399-x","volume":"15","author":"D Hashemi Karoii","year":"2024","unstructured":"Hashemi Karoii, D. et al. Exploring the interaction between immune cells in the prostate cancer microenvironment combining weighted correlation gene network analysis and single-cell sequencing: An integrated bioinformatics analysis. Discover. Oncol. 15(1), 513 (2024).","journal-title":"Discover. Oncol."},{"issue":"4","key":"11457_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/genes13040655","volume":"13","author":"MM Khan","year":"2022","unstructured":"Khan, M. M. et al. Identification of potential key genes in prostate cancer with gene expression, pivotal pathways and regulatory networks analysis using integrated bioinformatics methods. Genes 13(4), 655 (2022).","journal-title":"Genes"},{"issue":"2","key":"11457_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247827","volume":"16","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis. PLoS ONE 16(2), e0247827 (2021).","journal-title":"PLoS ONE"},{"issue":"19","key":"11457_CR4","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.3390\/cancers13194829","volume":"13","author":"N Sadeesh","year":"2021","unstructured":"Sadeesh, N., Scaravilli, M. & Latonen, L. Proteomic landscape of prostate cancer: The view provided by quantitative proteomics, integrative analyses, and protein interactomes. Cancers 13(19), 4829 (2021).","journal-title":"Cancers"},{"issue":"2","key":"11457_CR5","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.18632\/aging.202285","volume":"13","author":"X Yin","year":"2020","unstructured":"Yin, X. et al. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis. Aging (Albany NY) 13(2), 2519 (2020).","journal-title":"Aging (Albany NY)"},{"key":"11457_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.597888","volume":"11","author":"G Shi","year":"2020","unstructured":"Shi, G. et al. Identifying biomarkers to predict the progression and prognosis of breast cancer by weighted gene co-expression network analysis. Front. Genet. 11, 597888 (2020).","journal-title":"Front. Genet."},{"issue":"1","key":"11457_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12864-024-10506-9","volume":"25","author":"DH Karoii","year":"2024","unstructured":"Karoii, D. H., Azizi, H. & Skutella, T. Whole transcriptome analysis to identify non-coding RNA regulators and hub genes in sperm of non-obstructive azoospermia by microarray, single-cell RNA sequencing, weighted gene co-expression network analysis, and mRNA-miRNA-lncRNA interaction analysis. BMC Genom. 25(1), 583 (2024).","journal-title":"BMC Genom."},{"key":"11457_CR8","doi-asserted-by":"crossref","unstructured":"Tian, Z. et al. Identification of important modules and biomarkers in breast cancer based on WGCNA. OncoTargets Ther. 6805\u20136817 (2020).","DOI":"10.2147\/OTT.S258439"},{"issue":"2","key":"11457_CR9","first-page":"52","volume":"10","author":"Z Yanli","year":"2021","unstructured":"Yanli, Z. et al. Identification of functional gene modules and biomarkers of apatinib against lung adenocarcinoma based on weighted gene co-expression network ansalysis (WGCNA). Science 10(2), 52\u201364 (2021).","journal-title":"Science"},{"key":"11457_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12282-020-01101-3","volume":"27","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co-expression network analysis. Breast Cancer 27, 1017\u20131028 (2020).","journal-title":"Breast Cancer"},{"issue":"1","key":"11457_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12957-024-03459-6","volume":"22","author":"L Manouchehri","year":"2024","unstructured":"Manouchehri, L., Zinati, Z. & Nazari, L. Population-specific gene expression profiles in prostate cancer: insights from weighted gene co-expression network analysis (WGCNA). World J. Surg. Oncol. 22(1), 177 (2024).","journal-title":"World J. Surg. Oncol."},{"issue":"4","key":"11457_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/cell.2022.0025","volume":"24","author":"DH Karoii","year":"2022","unstructured":"Karoii, D. H., Azizi, H. & Amirian, M. Signaling pathways and protein\u2013protein interaction of vimentin in invasive and migration cells: A review. Cell. Reprogram. 24(4), 165\u2013174 (2022).","journal-title":"Cell. Reprogram."},{"issue":"3","key":"11457_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/ani12030268","volume":"12","author":"A Niazi Tabar","year":"2022","unstructured":"Niazi Tabar, A. et al. Testicular localization and potential function of vimentin positive cells during spermatogonial differentiation stages. Animals 12(3), 268 (2022).","journal-title":"Animals"},{"key":"11457_CR14","doi-asserted-by":"crossref","unstructured":"Feng, T., et al. Four novel prognostic genes related to prostate cancer identified using co-expression structure network analysis. Front. Genet. 12-2021 (2021).","DOI":"10.3389\/fgene.2021.584164"},{"issue":"18","key":"11457_CR15","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-09-0911","volume":"15","author":"MS Arredouani","year":"2009","unstructured":"Arredouani, M. S. et al. Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin. Cancer Res. 15(18), 5794\u20135802 (2009).","journal-title":"Clin. Cancer Res."},{"issue":"62","key":"11457_CR16","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.18632\/oncotarget.22289","volume":"8","author":"M Shan","year":"2017","unstructured":"Shan, M. et al. Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies. Oncotarget 8(62), 104761\u2013104771 (2017).","journal-title":"Oncotarget"},{"key":"11457_CR17","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/srep16018","volume":"5","author":"MM Mortensen","year":"2015","unstructured":"Mortensen, M. M. et al. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci. Rep. 5, 16018 (2015).","journal-title":"Sci. Rep."},{"issue":"2","key":"11457_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00109-012-0949-1","volume":"91","author":"R Kuner","year":"2013","unstructured":"Kuner, R. et al. The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer. J. Mol. Med. (Berl) 91(2), 237\u2013248 (2013).","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3","key":"11457_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2025.111046","volume":"117","author":"D Hashemi Karoii","year":"2025","unstructured":"Hashemi Karoii, D. et al. Identification of novel long non-coding RNA involved in Sertoli cell of non-obstructive azoospermia based on microarray and bioinformatics analysis. Genomics 117(3), 111046 (2025).","journal-title":"Genomics"},{"issue":"1","key":"11457_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12672-025-01926-4","volume":"16","author":"D Hashemi Karoii","year":"2025","unstructured":"Hashemi Karoii, D. et al. Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell\u2013cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer. Discover. Oncol. 16(1), 177 (2025).","journal-title":"Discover. Oncol."},{"key":"11457_CR21","doi-asserted-by":"crossref","unstructured":"Hashemi Karoii, D. & Azizi, H. OCT4 Protein and Gene Expression Analysis in the Differentiation of Spermatogonia Stem Cells into Neurons by Immunohistochemistry, Immunocytochemistry, and Bioinformatics Analysis. Stem Cell Rev. Rep. 1\u201317 (2023).","DOI":"10.1007\/s12015-023-10548-8"},{"issue":"1","key":"11457_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12920-025-02087-7","volume":"18","author":"D Hashemi Karoii","year":"2025","unstructured":"Hashemi Karoii, D. et al. Identification of novel cytoskeleton protein involved in spermatogenic cells and sertoli cells of non-obstructive azoospermia based on microarray and bioinformatics analysis. BMC Med. Genom. 18(1), 19 (2025).","journal-title":"BMC Med. Genom."},{"key":"11457_CR23","doi-asserted-by":"crossref","unstructured":"Hashemi Karoii, D., Azizi, H., & Skutella, T. Altered G-protein transduction protein gene expression in the testis of infertile patients with nonobstructive azoospermia. DNA Cell Biol. (2023).","DOI":"10.1089\/dna.2023.0189"},{"issue":"8","key":"11457_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/cbf.3747","volume":"40","author":"D Hashemi Karoii","year":"2022","unstructured":"Hashemi Karoii, D., Azizi, H. & Skutella, T. Microarray and in silico analysis of DNA repair genes between human testis of patients with nonobstructive azoospermia and normal cells. Cell Biochem. Funct. 40(8), 865\u2013879 (2022).","journal-title":"Cell Biochem. Funct."},{"issue":"1","key":"11457_CR25","doi-asserted-by":"publisher","first-page":"25965","DOI":"10.1038\/s41598-024-77875-9","volume":"14","author":"D Hashemi Karoii","year":"2024","unstructured":"Hashemi Karoii, D. et al. Alteration of the metabolite interconversion enzyme in sperm and Sertoli cell of non-obstructive azoospermia: a microarray data and in-silico analysis. Sci. Rep. 14(1), 25965 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"11457_CR26","doi-asserted-by":"publisher","first-page":"17259","DOI":"10.1038\/s41598-022-22137-9","volume":"12","author":"M Amirian","year":"2022","unstructured":"Amirian, M. et al. VASA protein and gene expression analysis of human non-obstructive azoospermia and normal by immunohistochemistry, immunocytochemistry, and bioinformatics analysis. Sci. Rep. 12(1), 17259 (2022).","journal-title":"Sci. Rep."},{"issue":"2","key":"11457_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1667\/RR13515.1","volume":"181","author":"CG Broustas","year":"2014","unstructured":"Broustas, C. G. & Lieberman, H. B. DNA damage response genes and the development of cancer metastasis. Radiat. Res. 181(2), 111\u2013130 (2014).","journal-title":"Radiat. Res."},{"key":"11457_CR28","doi-asserted-by":"crossref","unstructured":"Lee, M. Deep Learning techniques with genomic data in cancer prognosis: A comprehensive review of the 2021\u20132023 literature. Biology (Basel). 12(7) (2023).","DOI":"10.3390\/biology12070893"},{"issue":"1","key":"11457_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li, K. et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct. Target. Ther. 6(1), 362 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"11457_CR30","doi-asserted-by":"crossref","unstructured":"Maekawa, S., Takata, R., & Obara, W. Molecular mechanisms of prostate cancer development in the precision medicine era: A comprehensive review. Cancers (Basel). 16(3) (2024).","DOI":"10.3390\/cancers16030523"},{"issue":"3","key":"11457_CR31","first-page":"301","volume":"1","author":"X Wang","year":"2011","unstructured":"Wang, X. & Weaver, D. T. The ups and downs of DNA repair biomarkers for PARP inhibitor therapies. Am. J. Cancer Res. 1(3), 301\u2013327 (2011).","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"11457_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1158\/0008-5472.CAN-17-1924","volume":"78","author":"AM Horning","year":"2018","unstructured":"Horning, A. M. et al. Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response. Cancer Res. 78(4), 853\u2013864 (2018).","journal-title":"Cancer Res."},{"key":"11457_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105398","volume":"109","author":"F Zhao","year":"2024","unstructured":"Zhao, F. et al. Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression. EBioMedicine 109, 105398 (2024).","journal-title":"EBioMedicine"},{"issue":"1","key":"11457_CR34","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1634\/theoncologist.2019-0244","volume":"25","author":"SJ Klempner","year":"2020","unstructured":"Klempner, S. J. et al. Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: A review of current evidence. Oncologist 25(1), e147\u2013e159 (2020).","journal-title":"Oncologist"},{"issue":"9375","key":"11457_CR35","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","volume":"361","author":"MK Parmar","year":"2003","unstructured":"Parmar, M. K. et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial. Lancet 361(9375), 2099\u20132106 (2003).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11457-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:28:49Z","timestamp":1757255329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11457-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11457"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11457-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26117"}}